Cano-Ibáñez, Naomi http://orcid.org/0000-0002-3640-5486
Quintana-Navarro, Gracia M. http://orcid.org/0000-0003-4413-4062
Alcala-Diaz, Juan F. http://orcid.org/0000-0002-4572-3611
Rangel-Zuñiga, Oriol A. http://orcid.org/0000-0003-3495-5705
Camargo, Antonio http://orcid.org/0000-0002-0415-4184
Yubero-Serrano, Elena M. http://orcid.org/0000-0002-2733-5359
Perez-Corral, Isabel
Arenas-de Larriva, Antonio P. http://orcid.org/0000-0001-8897-5176
Garcia-Rios, Antonio http://orcid.org/0000-0001-7320-9006
Perez-Martinez, Pablo http://orcid.org/0000-0001-7716-8117
Delgado-Lista, Javier http://orcid.org/0000-0002-2982-2716
Lopez-Miranda, Jose http://orcid.org/0000-0001-9689-5918
Clinical trials referenced in this document:
Documents that mention this clinical trial
Sex-specific differences in intestinal microbiota associated with cardiovascular diseases
https://doi.org/10.1186/s13293-024-00582-7
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
https://doi.org/10.1186/s12933-023-01933-1
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
https://doi.org/10.1007/s00394-022-03080-x
Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
https://doi.org/10.1007/s00394-022-02854-7
Mediterranean Diet Reduces Atherosclerosis Progression in Coronary Heart Disease: An Analysis of the CORDIOPREV Randomized Controlled Trial
https://doi.org/10.1161/strokeaha.120.033214
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
https://doi.org/10.1186/s12933-021-01260-3
CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics
https://doi.org/10.1016/j.ahj.2016.04.011
A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study
https://doi.org/10.1007/s00394-021-02676-z
Funding for this research was provided by:
Juan de la Cierva formación programme
Nicolas Monardes programme
Río Hortega programme
Fundacion Patrimonio Comunal Olivarero
Ministerio de Ciencia e Innovacion (AGL2009-122270)
Ministerio de Ciencia e Innovación (PI10/01041, PI13/00023)
Ministerio de Economía y Competitividad (AGL2012/39615)
Consejeria de Salud, Junta de Andalucia (PI0193/09)
consejería de salud, junta de andalucía (PI-0252/09)
Consejería de Salud, Junta de Andalucía (PI-0058/10, PI-0206-2013)
Consejería de Economía, Innovación, Ciencia y Empleo (CVI-7450)
Universidad de Córdoba
Article History
Received: 27 September 2021
Accepted: 22 February 2022
First Online: 29 March 2022
Change Date: 3 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00394-022-03006-7
Declarations
:
: The authors declare that they have no current or potential conflicts of interest.
: The protocol was written in accordance with the principles of the Declaration of Helsinki. The respective Institutional Review Board (IRB) by the Human Investigation Review Committee of the Reina Sofia University Hospital (Córdoba, Spain) approved the study protocol. The trial was registered in 2009 at ClinicalTrials.gov (number NCT00924937). Recruitment took place from July 2009 to February 2012. All subjects provided written informed consent.